肾移植术后首年静息与活化靶细胞群中麦考酚酸药效学评估
该研究在肾移植术后第一年内纵向监测外周血单核细胞中IMPDH活性和嘌呤水平,评估麦考酚酸(MPA)的药效学。结果显示MPA对刺激后PBMC的抑制作用更强,非刺激PBMC在术后1年内对MPA敏感性降低,早期IMPDH活性可能预测剂量减少。
要点
- MPA对刺激后PBMC的IMPDH抑制更强,服药后1.5小时抑制最深。
- 非刺激PBMC在术后1年内对MPA敏感性逐渐降低,1年时IMPDH活性恢复至术前水平。
- 术后6-9天非刺激PBMC的谷浓度IMPDH活性较低者,第一年内更可能需要减量。
核心结论
- MPA对刺激后PBMC的抑制作用强于非刺激PBMC。
- 肾移植术后第一年内非刺激PBMC对MPA的敏感性降低。
- 早期IMPDH活性可能预测第一年内的MPA剂量减少。
研究设计与样本
- 前瞻性纵向观察研究,纳入肾移植受者,在术前0-4天及术后6-9天、5-7周、1年(服药前和服药后1.5小时)采集PBMC。
- 在刺激和非刺激PBMC中测定IMPDH活性和嘌呤(鸟嘌呤和腺嘌呤)水平。
主要发现
- 刺激PBMC的IMPDH活性(pmol 10^-6 cells min^-1)中位数(IQR):术前127(95.8-147),术后各时间点服药前44.9(19.2-93.2),服药后1.5小时12.1(4.64-23.6)。
- 非刺激PBMC的IMPDH活性对应为5.71(3.79-6.93)、3.35(2.31-5.62)和2.71(1.38-4.08)。
- 非刺激PBMC的服药前IMPDH活性随时间增加,1年时达到术前值。
- 刺激PBMC中,与术前相比,服药前嘌呤中位数降低39%,服药后降低69%;非刺激PBMC中嘌呤水平无变化。
临床怎么用
- 监测PBMC中IMPDH活性可能有助于评估MPA的药效学效应。
- 术后早期IMPDH活性或可辅助预测MPA剂量调整需求。
- 需注意MPA对活化与静息PBMC的抑制程度不同。
局限性
- 观察性研究,未设置对照组。
- 仅随访至术后1年,长期数据未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To explore the pharmacodynamics of mycophenolic acid (MPA) through inosine monophosphate dehydrogenase (IMPDH) capacity measurement and purine levels in peripheral blood mononuclear cells (PBMC) longitudinally during the first year after renal transplantation (TX). METHODS: PBMC were isolated from renal recipients 0-4 days prior to and 6-9 days, 5-7 weeks and 1 year after TX (before and 1.5 hours after dose). IMPDH capacity and purine (guanine and adenine) levels were measured in stimulated and nonstimulated PBMC. RESULTS: Twenty-nine patients completed the follow-up period, of whom 24 received MPA. In stimulated PBMC, the IMPDH capacity (pmol 10-6 cells min-1 ) was median (interquartile range) 127 (95.8-147) before TX and thereafter 44.9 (19.2-93.2) predose and 12.1 (4.64-23.6) 1.5 hours postdose across study days after TX. The corresponding IMPDH capacity in nonstimulated PBMC was 5.71 (3.79-6.93), 3.35 (2.31-5.62) and 2.71 (1.38-4.08), respectively. Predose IMPDH capacity in nonstimulated PBMC increased with time, reaching pre-TX values at 1 year. In stimulated PBMC, both purines were reduced before (median 39% reduction across days after TX) and after (69% reduction) dose compared to before TX. No alteration in the purine levels was observed in nonstimulated PBMC. Patients needing dose reductions during the first year had lower pre-dose IMPDH capacity in nonstimulated PBMC (1.87 vs 3.00 pmol 10-6 cells min-1 , P = .049) at 6-9 days. CONCLUSION: The inhibitory effect of MPA was stronger in stimulated PBMC. Nonstimulated PBMC became less sensitive to MPA during the first year after TX. Early IMPDH capacity appeared to be predictive of dose reductions.
引用
- Klaasen RA, Bergan S, Bremer S, et al. Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation. Br J Clin Pharmacol. 2020. PMID: 31925806. doi:10.1111/bcp.14218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。